Cure8

Why This Matters

Highlights variation in physician confidence to start biologics in Pakistan and links between training exposure and use of advanced therapies; points to access, cost, and infection-screening as practical barriers that can affect care for people with IBD.

Who Should Pay Attention

Clinicians treating IBD, IBD trainers and program directors, health system planners, and patient advocates in Pakistan and similar settings.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This paper reports survey results (not a clinical trial). Most respondents were formally trained gastroenterologists. Physicians with overseas training were more likely to feel confident initiating biologics for both ulcerative colitis and Crohn’s disease.

Higher confidence was associated with earlier use of advanced therapies (including anti-TNF agents and oral targeted therapies).

Commonly reported barriers included infection-screening challenges, medication cost, and limited access, and the authors suggest strengthening IBD-focused training and addressing systemic barriers to improve guideline-concordant care.

Keep In Mind

Survey-based results reflect self-report and associations; they do not provide direct evidence on patient outcomes or efficacy. Findings are grounded in the article abstract and full-text survey report.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationInflammatory intestinal diseases
AuthorsAzad T, Mushtaq J, Tayyab GN +6 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJan 1, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →